EUROQOL | News
EuroQol animation, ‘Translating patient reported outcome measures for use around the World: The Example of EQ-5D’ is now also available in Chinese, Japanese and Spanish
EuroQol is excited to announce the publication of Chinese (Mandarin), Japanese and Spanish versions of our latest whiteboard animation. This animation provides a step-by-step overview of how to translate a PROM by showing how EuroQol…
Interviewer Administered Proxy 1 versions of the EQ-5D now available in 30 languages
EuroQol is pleased to announce that its Version Management Committee has recently approved 30 language versions of the Interviewer Administered (IA) Proxy 1 EQ-5D variant. The Proxy 1 IA version is available in 28 languages…
New version of the EQ-5D-Y User Guide now available for download!
The EuroQol Office is pleased to announce that a new version of the EQ-5D-Y User Guide is available for download. The guide provides users with information on how to analyse, score and present results from…
New update of official guide to the methods of economic evaluation for France recommends use of EQ-5D-5L to derive a utility score
The French National Authority for Health (Haute Autorité de Santé or HAS) has recently published its first update of its official methodological guide for economic evaluation (Choix méthodologiques pour l'évaluation économique à la HAS). One…
Comprehensive guide on how to analyse EQ-5D data is published
We welcome the publication of the detailed guide by Prof. Nancy Devlin, Prof. David Parkin and Dr Bas Janssen on how to analyse and report data produced by the EQ-5D. The authors have explained methods…
EuroQol launches a new whiteboard animation, ‘Translating patient reported outcome measures for use around the world: the example of EQ-5D’
EuroQol is proud to announce the launch of a new whiteboard animation 'Translating patient reported outcome measures for use around the world: the example of EQ-5D’ , providing a step-by-step overview of how to translate…
Study team appointed for the new UK EQ-5D-5L valuation study
The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s…
EQ-5D is the most commonly cited multi-attribute utility instrument in review of national pharmacoeconomic guidelines
A review identifying which multi-attribute utility instruments (MAUIs) are recommended for use in official national pharmacoeconomic (PE) guidelines has been published in the European Journal of Health Economics. The study reviewed PE guidelines where health…
First EuroQol approved sign language version of the EQ-5D-5L is now available
EuroQol is pleased to announce the release of the British Sign Language (BSL) version of the EQ-5D-5L instrument. This is the first sign language version that has been approved by EuroQol. The EuroQol Board and…
Chinese version of the EQ-5D-5L User Guide now available for download
The EuroQol Office is pleased to announce that the EQ-5D-5L User Guide is now available in Chinese (Mandarin). The User Guide provides readers with basic information on how to use the EQ-5D-5L questionnaire. Topics include…